Id |
Subject |
Object |
Predicate |
Lexical cue |
TextSentencer_T1 |
0-155 |
Sentence |
denotes |
Expression of beta-galactoside alpha2,6 sialyltransferase and of alpha2,6-sialylated glycoconjugates in normal human liver, hepatocarcinoma, and cirrhosis. |
T1 |
0-155 |
Sentence |
denotes |
Expression of beta-galactoside alpha2,6 sialyltransferase and of alpha2,6-sialylated glycoconjugates in normal human liver, hepatocarcinoma, and cirrhosis. |
T1 |
0-155 |
Sentence |
denotes |
Expression of beta-galactoside alpha2,6 sialyltransferase and of alpha2,6-sialylated glycoconjugates in normal human liver, hepatocarcinoma, and cirrhosis. |
TextSentencer_T2 |
156-281 |
Sentence |
denotes |
beta-Galactoside alpha2,6-sialyltransferase (ST6Gal.I) mediates the addition of alpha2,6-linked sialic acid to glycoproteins. |
T2 |
156-281 |
Sentence |
denotes |
beta-Galactoside alpha2,6-sialyltransferase (ST6Gal.I) mediates the addition of alpha2,6-linked sialic acid to glycoproteins. |
T2 |
156-281 |
Sentence |
denotes |
beta-Galactoside alpha2,6-sialyltransferase (ST6Gal.I) mediates the addition of alpha2,6-linked sialic acid to glycoproteins. |